中文 | English
Return
Total: 96 , 1/10
Show Home Prev Next End page: GO
Author:(Qin XUEMEI)

1.Analysis of AIDS Vaccine Patent Applied in America

Xuemei QIN ; Dongmei ZHANG

China Pharmacy 2016;27(7):869-871

2.Clinical study on plasma orexin-A levels in patients with chronic obstructive pulmonary disease.

Xuemei LIAO ; Qin YU

Chinese Journal of Practical Internal Medicine 2000;0(11):-

3.Comparison of chemical composition between raw and vinegar-baked Paeoniae Radix Alba using NMR based metabolomic approach.

Zhenyu LI ; Mali FAN ; Xuemei QIN

Acta Pharmaceutica Sinica 2015;50(2):211-7

4.Research Advances on Triterpenoid Saponins Biosynthesis and Its Key Enzymes

Xiaoshuang XU ; Fusheng ZHANG ; Xuemei QIN

World Science and Technology-Modernization of Traditional Chinese Medicine 2014;(11):2440-2448

5.Cerebral venous sinus thrombosis caused by

Xuemei Qin ; Xiaoming Zhang ; Qingying Zhang

Neurology Asia 2012;17(3):227-230

6.Comparative study on main components of Chrysanthemum morifolium introduced in Ruicheng in Shanxi Province

Liming XUE ; Xuemei QIN ; Jigang GUO

Chinese Traditional and Herbal Drugs 1994;0(05):-

7.Effect of hydrogen-rich saline on TNF-α, NF-κB and apoptosis in skin flap after ischemia/reperfusion injury

Ling ZHAO ; Youbin WANG ; Shirui QIN ; Xuemei MA

Chinese Journal of Medical Aesthetics and Cosmetology 2013;(2):130-133

8.Monitoring of chemical components with different color traits of Tussilago farfara using NMR-based metabolomics.

Xi MI ; Zhenyu LI ; Xuemei QIN ; Lizeng ZHANG

Acta Pharmaceutica Sinica 2013;48(11):1692-7

9.Chemical comparison of different Farfarae Flos by NMR-based metabolomic approaches.

Zhengzheng ZHANG ; Haijuan ZHI ; Xuemei QIN ; Zhenyu LI

Acta Pharmaceutica Sinica 2015;50(5):599-604

10.Metabolomics study of doxorubicin induced hepatotoxicity.

Qianyun NIU ; Yuetao LIU ; Zhenyu LI ; Xuemei QIN

Acta Pharmaceutica Sinica 2015;50(6):708-13

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 96 , 1/10 Show Home Prev Next End page: GO